Qiang Gao - Sinovac Biotech Vice President Research and Development

  President
Mr. Qiang Gao serves as Vice President Research and Development of the company. Mr. Gao joined Sinovac Beijing in 2002 and has served as quality control manager, quality assurance manager, RD manager and RD director at Sinovac Beijing in the past years, and the general manager of Sinovac RD since 2010. He is responsible for developing our new vaccine products, including EV71 vaccine
Age: 40  President Since 2016      
86-10-5693-1800  http://www.sinovacbio.com
Gao received a master?s degree and a bachelor?s degree in microbiology from the University of Agriculture, PRC.

Management Efficiency

The company has Return on Asset of 6.42 % which means that on every $100 spent on asset it made $6.42 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 11.53 % implying that it generated $11.53 on every 100 dollars invested.
The company has 20.98M in debt with debt to equity (D/E) ratio of 6.9 . This implies that the company may be unable to create cash to meet all of its financial commitments. Sinovac Biotech has Current Ratio of 4.91 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

Joyce LeeZoetis
2012
James MichaudPerrigo Company plc
2016
Alok SonigDr Reddys Laboratories Ltd
2015
Jeffrey ChodakewitzVertex Pharmaceuticals Incorpor
2014
K RaoDr Reddys Laboratories Ltd
2016
Daniel PlewRegeneron Pharmaceuticals
2016
Jay MarkowitzRegeneron Pharmaceuticals
2017
Saumen ChakrabortyDr Reddys Laboratories Ltd
2018
Peter PowchikRegeneron Pharmaceuticals
2006
Louis YuPerrigo Company plc
2013
Heidi ChenZoetis
2012
Samiran DasDr Reddys Laboratories Ltd
2016
Roman TrawickiZoetis
2015
Reshma KewalramaniVertex Pharmaceuticals Incorpor
2018
Michael StewartPerrigo Company plc
2004
George YancopoulosRegeneron Pharmaceuticals
2016
Charles WagnerVertex Pharmaceuticals Incorpor
2019
Michael PariniVertex Pharmaceuticals Incorpor
2017
Stefan WeiskopfZoetis
2013
Glenn DavidZoetis
2016
Douglas BoothePerrigo Company plc
2013

Entity Summary

Sinovac Biotech Ltd., a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of vaccines against human infectious diseases in the Peoples Republic of China. Sinovac Biotech Ltd. was founded in 1999 and is based in Beijing, the Peoples Republic of China. Sinovac Biotech operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 735 people.Sinovac Biotech Ltd (SVA) is traded on BATS Exchange in USA and employs 735 people.

Sinovac Biotech Leadership Team

Weidong Yin, Chairman, CEO and President Managing Director, Secretary, Chairman of Sinovac Hong Kong, Chairman of Tangshan Yian, Chairman of Sinovac Dalian and Director of Sinovac Biotech Co
Meng Mei, Independent Director
Pengfei Li, Director
Simon Anderson, Independent Director
Shan Fu, Independent Director
Stephanie Carrington, IR Contact Officer
Guowei Wang, Director
Nan Wang, CFO and VP of Bus. Devel.
Fung Hoi, Director
Jing Li, Vice President Quality and Production
Helen Yang, IR Contact Officer
Yuk Lo, Independent Director
Jue Lee, Independent Director
Xiaomei Yin, Vice President Sales and Marketing
Jianzeng Cao, Director
Qiang Gao, Vice President Research and Development
Ming Xia, VP of Sales and Marketing

Stock Performance Indicators

Current Sentiment - SVA

Sinovac Biotech Investor Sentiment

Greater number of Macroaxis users are at this time bullish on Sinovac Biotech Ltd. What is your outlook on investing in Sinovac Biotech Ltd? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Currently Active Assets on Macroaxis

FB   
Purchased few shares of
a day ago
Traded for 188.14
VMW   
Purchased a lot of shares of
a day ago
Traded for 150.35
V   
Purchased few shares of
a day ago
Traded for 175.29
CRM   
Purchased a lot of shares of
a day ago
Traded for 152.77
F   
Purchased over 300 shares of
a day ago
Traded for 9.25
See also World Market Map. Please also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Search macroaxis.com